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the degraded specifi c substrate. Until now there 
have been more than 20 MMPs enzymes found. 
It is assumed that MMPs can interfere with cell 
behavior including cell apoptosis, migration, and 
proliferation.1 
Matrix metalloproteinase-9 has telopeptidase 
activity toward collagen and agrecanase,  the 
minor components of joint cartilage, thus MMP-
9 is presumed to play a role in bone resorption. 
Rheumatoid arthritis (RA) itself is an autoimmune 
disease mainly affecting the joints besides other 
organs. The disease is indicated with symmetrical 
synovitis and bone erosion with the fi nal result of 
joint deformity. There is a rather complex cytokine 
network in RA, but the dominant proinfl ammatory 
cytokines are tumor necrosis factor α (TNFα) and 
interleukin-1.2
Posthumus et al and Young Min et al reported 
that the high level of MMP-3 was correlated with 
the progression of radiographic joint damage, 
hence the high level of MMP-3 at the initial time 
of diagnosis is the reason to give anti-TNFα.3,4 
However, Tsukuhara reported that genetic 
polymorphism promoting MMP-3 in AR patient 
in Japan did not infl uence the joint damage. It 
was different from the RA population in Europe.5 
Gruber et al stated that there was increase of MMP-
9 level in RA patients.  Chang et al also reported the 
increase of MMP-9 level in RA patients in Taiwan. 
Matrix metalloproteinase-9 was thought to play a 
role in joint damage in RA.6,7
It is assumed that MMP-9 plays more roles than 
other MMPs in joint damage in RA. Meanwhile, 
other “traditional” infl ammatory markers such 
as rheumatoid factor (RF) and erythrocyte 
sedimentation rate (ESR) are still being used often 
to predict radiological damage. Based on those 
ideas, we wanted to study the correlation of MMP-
9 level, ESR, RF, and the duration of illness with 
radiographic joint damage in RA patients.
METHODS
Study design 
This was a cross-sectional study conducted at 
rheumatology clinic at Cipto Mangunkusumo 
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Background:  Rheumatoid arthritis (RA) is a common 
autoimmune disease of the joint indicated by chronic 
infl ammation of synovium, cartilage destruction, and 
osteopenia. The end results of RA are joint deformity 
and disability that will decrease the quality of life of 
the patients. Until now there is not a specifi c marker 
to assess the process of joint and bone damage in 
RA. Available markers such as C-reactive protein and 
erythrocyte sedimentation rate (ESR) indicate more 
about the infl ammatory status of the patient. The 
discovery of matrix metalloproteinases (MMPs) enzyme 
overexpression in RA has brought a new hope for the 
discovery of more specifi c markers of joint damage.
Objective:  To study the correlation of MMP-9 level, 
ESR, rheumatoid factor (RF), and the duration of illness 
with joint damage in RA patients.
Methods:  A cross-sectional study was conducted 
on RA outpatients in rheumatology clinic at Cipto 
Mangunkusumo General Hospital, Jakarta from January 
to October 2009. From the patients who fulfi lled the 
inclusion criteria and did not fulfi ll the exclusion criteria, 
blood sample was collected for MMP-9 level, RF, and 
ESR examinations; hand radiography (posterior-anterior 
view) was also taken.
Results:  From the study of 46 patients, we found 
a signifi cant correlation between MMP-9 level and 
radiographic feature of bone erosion (r = 0.3, p = 0.02) 
and between the duration of illness and Sharp score (r 
= 0.36, p = 0.014). There was no correlation between 
ESR and radiological fi ndings nor between RF and 
radiological fi ndings. Linear regression analysis showed 
the duration of illness as the most infl uencing factor to 
radiological fi ndings in RA patients.
Conclusion:  We found a signifi cant correlation 
between MMP-9 level and radiographic feature of 
bone erosion, and between the duration of illness and 
radiological fi ndings in RA patients.
Matrix metalloproteinases (MMPs) are a group of 
enzymes fi rst known to be involved in morphologic 
changes of tadpole. This group of enzymes, 
later known to be able to degrade the substrate 
of extracellular matrix, is categorized based on 
Correlation of matrix metalloproteinase-9 level, 
erythrocyte sedimentation rate, rheumatoid factor, 
and the duration of illness with radiological fi ndings in 
rheumatoid arthritis patients
G Aji,1 IARW Manuaba,2 JA Ongkowijaya,3 B Setiyohadi,3 Sumariyono3 
Original Article
22 Indonesian Journal of Rheumatology 2010; Vol 03
General Hospital (CMGH), Jakarta involving 46 RA patients 
from January to October 2009. The sample size was calculated 
using formula for correlation coeffi cient for single sample. 
Dependent variable in this study was radiological Sharp score, 
while the independent variables were MMP-9 level, ESR, RF 
level, and the duration of illness.
Subjects
Inclusion criteria were RA patients fulfi lling the 1987 American 
College of Rheumatology criteria and agreed to be included in 
the study. Patients with chronic kidney disease, malignancy, 
chronic obstructive pulmonary disease, and systemic infection 
were excluded from the study. The study protocol had been 
approved by the appropriate local ethical board. All patients 
were then asked to give informed consent.
Measurement
Blood was collected for MMP-9 level, RF level, and ESR 
examinations. Matrix metalloproteinase-9 was examined in 
duplicate using enzyme-linked immunosorbent assay method 
from Bender MedSystem GmbH performed at Integrated 
Laboratory (Makmal Terpadu) at University of Indonesia 
School of Medicine, Jakarta. The result was in ng/mL. 
ESR was stated in mm/hour and RF was in IU/mL. Hand 
radiography with posterior-anterior view was also performed 
on the subjects with computed tomography at Department of 
Radiology at CMGH using Kodak CR975 System. The images 
were then interpreted by consultant radiologist and reported as 
Sharp score. Sharp score is a cumulative of two scores: joint 
space narrowing score in 16 hand joint area (0 = no joint space 
narrowing to 4 = no joint space) and bone erosion score in 17 
hand joint area  (0 = no bone erosion to 5 = extending erosion).
Statisitical methods
The collected data were analyzed using Statistical Package 
for the Social Sciences (SPSS) program. We used multivariate 
analysis for statistical test of subject characteristics and 
bivariate analysis for correlation test using Pearson’s 
correlation test (or Spearman’s test for abnormally distributed 
data), then continued with multivariate analysis. 
RESULTS
Of the 46 subjects we found the characteristics as follows: 40 
subjects (87.0%) were female  and 6  subjects (13.0%) were 
male. Mean age was 48.61 years and mean duration of illness 
was 4.83 years. Mean tender joint count was 5.42 and mean 
swollen joint count was 2.54. Mean total Sharp score, erosion 
score, and joint space narrowing score were 8.76, 3.50, and 
5.37, respectively (table 1).
Table 1   Characteristics of subjects
Characteristics Median  (range)
Age, years   50.0    (29–67)
Tender joint count 003.0    (0–22)
Swollen joint count 000.0    (0–14)
ESR, mm/hr 052.20  (3–116)
RF level, IU/mL 022.77  (5.4–300)
MMP-9 level, ng/mL 112.17  (38.73–154.47)
Duration of illness, years 003.56  (1–14)
Joint space narrowing score 003.0    (0–21)
Bone erosion score 002.0    (0–18)
Total Sharp score 005.0    (0–34)
ESR, erythrocyte sedimentation rate; RF, rheumatoid factor; MMP-9, matrix 
metalloproteinase-9.
There was not any correlation of MMP-9 level, ESR, or 
RF with the total Sharp score, but there was a signifi cant 
correlation between the duration of illness and the total Sharp 
score (table 2). We also found a signifi cant correlation between 
MMP-9 level and bone erosion score (r = 0.3, p = 0.02). 
Table 2   Correlation of matrix metalloproteinase-9 (MMP-9) 
level, rheumatoid factor (RF) level, erythrocyte sedimentation 
rate (ESR), and the duration of illness with the Sharp score
Sharp score
r  (p Value)
MMP-9 level 0.181  (0.115)
RF level 0.194  (0.098)
ESR 0.104  (0.246)
Duration of illness 0.361  (0.014)
MMP-9, matrix metalloproteinase-9; RF, rheumatoid factor; ESR, erythrocyte 
sedimentation rate.
From the analysis of receiver operating characteristic 
curve, we obtained the cut-off point of 95.02 ng/mL for MMP-
9 level with 72.72% sensitivity and 40.00% specifi city. On the 
other hand, the cut-off point for the duration of illness was 
39.0 months with 75.0% sensitivity and 63.33% specifi city. In 
multivariate linear regression analysis we found the duration 
of illness as the most infl uencing factor to radiographic joint 
damage (r = 0.299, p = 0.043).
DISCUSSION
In this study we found that ESR and RF did not correlate 
with joint damage in RA patients. This result is different from 
previous studies done overseas. Caruso et al8 and Combe et al9 
reported that ESR was the prognostic factor for radiographic 
joint damage, while Vitttecoq et al10 reported that RF was 
the predictor for radiographic progression in RA patients. 
The difference in results could be caused in part by the study 
design used: those studies were prospective study, while ours 
was a cross-sectional study. We found a signifi cant correlation 
between MMP-9 level and bone erosion score (r = 0.3, p = 
0.02). It fi tted the theory that MMP-9 has telopeptidase activity 
toward collagen, thus it is assumed to play a role in bone 
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resorption. Engsig et al stated that MMP-9 plays important role 
in osteoclasts recruitment and migration to diaphysis in long 
bone formation, in conformity with theory stating that MMPs 
also play a role in cell behavior.11 Recruited osteoclasts in RA 
will become hyperactive through the receptor activator for 
nuclear factor-κB (RANK) protein in osteoclasts membrane, 
thus the osteoclasts would become active and resorp the 
bone. In this study, the duration of illness was signifi cantly 
correlated with radiological fi ndings (r = 0.36, p = 0.014). It 
fi tted the study of Caruso et al which stated that the duration 
of illness was the most important factor that correlates with 
radiographic joint damage.8
CONCLUSIONS
We found a signifi cant correlation between MMP-9 level and 
radiographic bone erosion, and between the duration of illness 
and radiological fi ndings in RA patients. Further studies are 
needed to investigate the role of MMPs in RA.
REFFERENCES
1. Okada Y. Proteinases and matrix degradation. In: Firestein GS, Budd RC, 
Harris Jr ED, McInnes IB, Ruddy S, Sergent JS, editors. Kelley’s textbook of 
rheumatology. 8th ed. Philadelphia: Saunders Elsevier; 2009. p. 115–31.
2. Waldenburger JM, Firestein GS. Rheumatoid arthritis: epidemiology, 
pathology, and pathogenesis. In: Klippel JH, Stone JH, Crofford LJ, 
White PH, editors. Primer on the rheumatic disease. 13th ed. New York: 
Springer; 2008. p. 122–32.
3. Posthumus MD, Limburg PC, Westra J, van Leeuwen MA, van Rijswijk 
MH. Serum matrix metalloproteinase-3 in early rheumatoid arthritis is 
correlated with disease activity and radiological progression. J Rheumatol 
2000;27(12):2761–8.
4. Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, 
et al. Biomarkers predict radiographic progression in early rheumatoid 
arthritis and perform well compared with traditional markers. Arthritis 
Rheum 2007;56:3236–47.
5. Tsukahara S, Shinozaki M, Ikari K, Mochizuki T, Inoue E, Tomatsu T, et 
al. Effect of matrix metalloproteinase-3 functional SNP on serum matrix 
metalloproteinase-3 level and outcome measures in Japanese RA 
patients. Rheumatology 2008;47:41–4.
6. Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, et 
al. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid 
artritis: a potentially useful laboratory marker. Clin Immunol Immunopathol 
1996;78:161–71.
7. Chang YH, Lin IL, Tsay GJ, Yang SC, Yang TP , Ho KT et al. Elevated 
circulatory MMP-2 and MMP-9 levels and activities in patients with 
rheumatoid arthritis and systemic lupus erythematous. Clin Biochem 
2008;41(12):955–9.
8. Caruso I, Santandrea S, Sarzi Puttini P, Boccassini L, Montrone F, Cazzola 
M, et al. Clinical, laboratory and radiographic features in early rheumatoid 
arthritis. J Rheumatol 1990;17(10):1263–7.
9. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, et al. 
Prognostic factors for radiographic damage in early rheumatoid arthritis: 
a multiparameter prospective study. Arthritis Rheum 2001;44(8):1736–
43.
10. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet 
A, et al. Rheumatoid factor is the strongest predictor of radiological 
progression of rheumatoid arthritis in a three-year prospective study in 
community-recruited patients. Rheumatology 2003;42:939–46.
11. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, et al. 
Matrix metalloproteinase-9 and vascular endothelial growth factor are 
essential for osteoclast recruitment into developing long bones. J Cell 
Biol 2000;151(4):879–89.
